Also known as A-17 bronchi peptide · respiratory peptide complex
A natural bronchial peptide complex (Cytomax A-17) — the extract-based counterpart to Bronchogen, targeting respiratory tissue.
Research refreshed
Taxorest is a natural peptide complex extracted from bronchial tissue (peptide complex A-17), part of the Russian Cytomax / Revilab bioregulator line. It is the extract-based respiratory counterpart to the synthetic tetrapeptide Bronchogen (Ala-Glu-Asp-Pro), marketed within the Khavinson tradition for bronchial and respiratory support.
Taxorest is the bronchi-directed natural bioregulator of the Cytomax / Revilab line. It pairs with Bronchogen, the synthetic Ala-Glu-Asp-Pro tetrapeptide already catalogued: Taxorest is the natural bronchial extract, Bronchogen the defined synthetic short peptide modeled on the same tissue.
As a tissue extract it is a standardized polypeptide fraction with no single molecular formula or sequence. Its respiratory claims come from the same concentrated research tradition as the rest of the series, with limited independent replication, and it is not FDA-approved.
Proposed tissue-selective (bioregulator) modulation of bronchial-epithelium gene expression, in the same lineage as the synthetic bronchi peptide Bronchogen.
Behind every vial of Taxorest is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Taxorest, specifically, is brought into being.
Taxorest begins not as a powder but as a specification. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Taxorest is assembled by solid-phase peptide synthesis — the chain grows one protected residue at a time on resin, and what you fail to build cleanly here you pay to remove later.
The crude mixture — Taxorest plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Taxorest proves itself: identity confirmed by mass spectrometry, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Taxorest — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Taxorest is a natural bronchial peptide extract (complex A-17), a fractionated polypeptide preparation rather than a synthesized peptide. Consistency and characterization of the extract determine its quality.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Taxorest is a natural bronchial peptide complex (Cytomax A-17), marketed for respiratory support — the extract-based counterpart to the synthetic peptide Bronchogen.
Taxorest is the natural bronchial extract; Bronchogen is the defined synthetic tetrapeptide (Ala-Glu-Asp-Pro) modeled on the same tissue.
No — it is a tissue extract (a polypeptide fraction), so it has no single sequence or molecular formula.
No — it is a research compound / supplement, not FDA-approved. This page is a research and educational reference.
Synthetic tetrapeptide investigated for telomerase activity and circadian effects.
ViewThe natural pineal peptide bioregulator — the animal-derived counterpart to synthetic Epitalon, marketed for aging and telomere support.
ViewThymus-derived polypeptide complex — the founding tissue bioregulator (Cytomax) studied for immune restoration.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.